Prothena Corp PLC (PRTA)
25.10
-0.97
(-3.72%)
USD |
NASDAQ |
Mar 18, 16:00
25.12
+0.02
(+0.08%)
After-Hours: 20:00
Prothena Enterprise Value: 729.55M for March 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
March 18, 2024 | 729.55M |
March 15, 2024 | 781.66M |
March 14, 2024 | 803.69M |
March 13, 2024 | 917.58M |
March 12, 2024 | 860.63M |
March 11, 2024 | 888.57M |
March 08, 2024 | 1.005B |
March 07, 2024 | 955.18M |
March 06, 2024 | 957.33M |
March 05, 2024 | 904.15M |
March 04, 2024 | 902.53M |
March 01, 2024 | 913.82M |
February 29, 2024 | 863.32M |
February 28, 2024 | 937.99M |
February 27, 2024 | 1.009B |
February 26, 2024 | 895.01M |
February 23, 2024 | 843.44M |
February 22, 2024 | 828.94M |
February 21, 2024 | 834.31M |
February 20, 2024 | 860.10M |
February 16, 2024 | 886.42M |
February 15, 2024 | 913.28M |
February 14, 2024 | 846.64M |
February 13, 2024 | 803.68M |
February 12, 2024 | 961.56M |
Date | Value |
---|---|
February 09, 2024 | 905.18M |
February 08, 2024 | 853.67M |
February 07, 2024 | 809.65M |
February 06, 2024 | 793.55M |
February 05, 2024 | 725.91M |
February 02, 2024 | 764.56M |
February 01, 2024 | 850.45M |
January 31, 2024 | 905.20M |
January 30, 2024 | 984.12M |
January 29, 2024 | 1.193B |
January 26, 2024 | 1.133B |
January 25, 2024 | 1.102B |
January 24, 2024 | 1.149B |
January 23, 2024 | 1.190B |
January 22, 2024 | 1.210B |
January 19, 2024 | 1.155B |
January 18, 2024 | 1.116B |
January 17, 2024 | 1.119B |
January 16, 2024 | 1.159B |
January 12, 2024 | 1.242B |
January 11, 2024 | 1.250B |
January 10, 2024 | 1.307B |
January 09, 2024 | 1.508B |
January 08, 2024 | 1.275B |
January 05, 2024 | 1.564B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-123.26M
Minimum
Aug 23 2019
3.460B
Maximum
May 05 2023
1.059B
Average
869.26M
Median
Enterprise Value Benchmarks
Amarin Corp PLC | 15.27M |
Jazz Pharmaceuticals PLC | 11.78B |
Iterum Therapeutics PLC | 5.601M |
GH Research PLC | 400.86M |
Mural Oncology PLC | 79.28M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -67.48M |
Revenue (Quarterly) | 0.316M |
Total Expenses (Quarterly) | 78.83M |
EPS Diluted (Quarterly) | -1.26 |
Profit Margin (Quarterly) | -21.35K% |
Earnings Yield | -11.16% |
Normalized Earnings Yield | -11.16 |